市場調查報告書
商品編碼
1451476
2024-2032 年人工角膜和角膜植入物市場報告(按類型、移植類型、疾病適應症、最終用戶和區域)Artificial Cornea and Corneal Implant Market Report by Type, Transplant Type, Disease Indication, End User, and Regional 2024-2032 |
2023年,全球人造角膜和角膜植入物市場規模達到4.399億美元。展望未來, IMARC Group預計到2032年市場規模將達到7.789億美元,2024-2032年複合年成長率(CAGR)為6.58%。角膜感染和眼部相關疾病的盛行率不斷上升,各種醫療設施的建設不斷增加,以及全層角膜移植的需求不斷增加,是推動市場發展的一些關鍵因素。
人工角膜和角膜植入物是指用從捐贈者獲得的健康且未受影響的角膜組織替換受損角膜的部分的特定外科手術。它們包括多種醫療程序,例如穿透性角膜移植和內皮性角膜移植術,其中涉及整個角膜幹細胞的移植。它們涉及植入物的移植,這些植入物本質上是水凝膠,由重組膠原蛋白製成,並插入患者角膜上的微小切口中。這些手術主要用於治療傳染性角膜炎、圓錐角膜、角膜潰瘍和福克斯營養不良性疾病。人工角膜和角膜植入物對於治療前角膜病變也是必要的,例如沙眼、感染性角膜炎、眼睛外傷和化學損傷。它們有助於改善視力、緩解疼痛、維持角膜的正確形狀以及治療嚴重感染或損傷。它們還可以幫助患有角膜疤痕和角膜疾病的患者恢復清晰的視力,使他們能夠輕鬆地進行日常活動。
目前,由於大眾角膜感染和眼部相關疾病的盛行率不斷上升,對人工角膜和角膜植入物的需求不斷增加,這是對市場產生正面影響的主要因素之一。除此之外,醫院、療養院和眼科診所等各種醫療設施的持續建設,為病患提供有效的治療,提供了良好的市場前景。此外,年輕人因長時間看智慧型手機或在電腦和筆記型電腦上工作而導致視力併發症的發生率不斷上升,也推動了市場的成長。除此之外,由於全球老年人口的不斷增加,對全層角膜移植的需求不斷增加,也促進了市場的成長。此外,擴大採用微創(MI)角膜移植方法來避免疤痕、縮短恢復期、減少費用和住院時間。再加上人們越來越傾向於穿透性角膜移植手術來治療老年患者的眼部相關併發症,支撐了市場的成長。此外,各種創新有效的醫療產品的使用不斷增加,例如在治療角膜疾病方面具有更好生物相容性和可自訂性的3D(3D)列印人工角膜,正在加強市場成長。
The global artificial cornea and corneal implant market size reached US$ 439.9 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 778.9 Million by 2032, exhibiting a growth rate (CAGR) of 6.58% during 2024-2032. The growing prevalence of corneal infections and eye-associated disorders, rising construction of various healthcare facilities, and escalating demand for full-thickness corneal transplantation represent some of the key factors driving the market.
Artificial cornea and corneal implant refer to specific surgical procedures conducted to replace segments of the damaged cornea with healthy and unaffected corneal tissue obtained from a donor. They consist of a wide variety of medical procedures, such as penetrating and endothelial keratoplasty, which involves the transplantation of the entire corneal stem cells. They involve transplantation of implants that are hydrogels in nature and manufactured with recombinant collagen and inserted in a tiny incision made on the cornea of the patient. These procedures are primarily performed for the treatment of infectious keratitis, keratoconus, corneal ulcers, and Fuchs dystrophy diseases. Artificial cornea and corneal implant are also necessary for curing anterior corneal pathologies, such as trachoma, infectious keratitis, ocular trauma, and chemical injuries. They help improve eyesight, relieve pain, maintain the proper shape of the cornea, and treat severe infections or damage. They also assist in restoring a clear vision of patients suffering from corneal scarring and corneal diseases and enable them to perform daily activities effortlessly.
At present, the increasing demand for artificial cornea and corneal implants due to the rising prevalence of corneal infections and eye-associated disorders among the masses represents one of the primary factors influencing the market positively. Besides this, the growing construction of various healthcare facilities, such as hospitals, nursing homes, and eye clinics, to provide effective treatment to patients is offering a favorable market outlook. In addition, the rising occurrence of eyesight complications among young individuals for spending prolonged hours looking at smartphones or working on computers and laptops is propelling the growth of the market. Apart from this, the increasing demand for full-thickness corneal transplantation due to the rising geriatric population worldwide is contributing to the growth of the market. Additionally, there is a rise in the adoption of minimally invasive (MI) corneal transplantation methods to avoid scarring, fasten the recovery period, and reduce the costs and duration of hospital stays. This, coupled with the increasing preference for penetrating keratoplasty procedures to treat eye-related complications in older patients, is supporting the market growth. Moreover, the rising utilization of various innovative and effective medical products, such as three-dimensional (3D) printed artificial cornea with better biocompatibility and customizability in treating corneal diseases, is strengthening the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global artificial cornea and corneal implant market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, transplant type, disease indication and end user.
Human Cornea
Artificial Cornea
The report has provided a detailed breakup and analysis of the artificial cornea and corneal implant market based on the type. This includes human cornea and artificial cornea. According to the report, human cornea represented the largest segment.
Penetrating Keratoplasty
Endothelial Keratoplasty
Anterior Lamellar Keratoplasty
Keratoprosthesis
A detailed breakup and analysis of the artificial cornea and corneal implant market based on the transplant type has also been provided in the report. This includes penetrating keratoplasty, endothelial keratoplasty, anterior lamellar keratoplasty, and keratoprothesis. According to the report, penetrating keratoplasty accounted for the largest market share.
Fuchs' Dystrophy
Fungal Keratitis
Keratoconus
Others
A detailed breakup and analysis of the artificial cornea and corneal implant market based on the disease indication has also been provided in the report. This includes Fuchs' dystrophy, fungal keratitis, keratoconus, and others. According to the report, Fuchs' dystrophy accounted for the largest market share.
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
A detailed breakup and analysis of the artificial cornea and corneal implant market based on the end user also been provided in the report. This includes hospitals, ambulatory surgical centers, and specialty clinics. According to the report, hospitals accounted for the largest market share.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (the United Kingdom, Germany, France, Italy, Spain, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for artificial cornea and corneal implant. Some of the factors driving the North America artificial cornea and corneal implant market included the aging population, rising advancements in eye care treatment procedures, improving healthcare expenditure, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global artificial cornea and corneal implant market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Advancing Sight Network, AJL Ophthalmic S.A., Aurolab, Corneat Vision Ltd, EyeYon Medical, Florida Lions Eye Bank, Keramed Inc., L V Prasad Eye Institute, LinkoCare Life Sciences AB, Mediphacos, Presbia PLC, San Diego Eye Bank, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.